Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

Targeting the upstream transcriptional activator of PD-L1 as an alternative strategy in melanoma therapy

Abstract

Programmed cell death ligand 1 (PD-L1) interacts with programmed cell death protein-1 (PD-1) as an immune checkpoint. Reactivating the immune response by inhibiting PD-L1 using therapeutic antibodies provides substantial clinical benefits in many, though not all, melanoma patients. However, transcriptional suppression of PD-L1 expression as an alternative therapeutic anti-melanoma strategy has not been exploited. Here we provide biochemical evidence demonstrating that ultraviolet radiation (UVR) induction of PD-L1 in skin is directly controlled by nuclear factor E2-related transcription factor 2 (NRF2). Depletion of NRF2 significantly induces tumor infiltration by both CD8+ and CD4+ T cells to suppress melanoma progression, and combining NRF2 inhibition with anti-PD-1 treatment enhanced its anti-tumor function. Our studies identify a critical and targetable PD-L1 upstream regulator and provide an alternative strategy to inhibit the PD-1/PD-L1 signaling in melanoma treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41388-018-0314-0

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 52 references

Cited by

See all 120

Metadata

Authors
Zhu, B., Tang, L., Chen, S., Yin, C., Peng, S., Li, X., Liu, T., Liu, W., Han, C., Stawski, L., Xu, Z.-X., Zhou, G., Chen, X., Gao, X., Goding, C. R., Xu, N., Cui, R., & Cao, P.
Affiliations
  • Boston University (US)
  • Nanjing University of Chinese Medicine (CN)
  • Central South University (CN)
  • Tianjin University of Traditional Chinese Medicine (CN)
  • University of Oxford (GB)
  • Tongji University (CN)
Corresponding author
  • Xu, Nan
  • Cui, Rutao
  • Cao, Peng
Venue
Oncogene
Published
2018-05-22
Volume
37
Issue
36
Pages
4941-4954
ISSN
  • 0950-9232 (ISSN-L)
  • 1476-5594
OpenAlex
W2803508781
Cited by
117
References
52
Citations by year
2026: 6 · 2025: 17 · 2024: 16 · 2023: 24 · 2022: 15 · 2021: 14 · 2020: 12 · 2019: 11 · 2018: 2
FWCI
3.66
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Oncogene (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Cancer Institute (R01CA193913, R01CA137098, R01CA196896)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
Keywords
PD-L1, melanoma, Nrf2, transcriptional regulation, ultraviolet radiation, immune checkpoint, PD-1/PD-L1 signaling, anti-PD-1 therapy, tumor-infiltrating T cells, tumor immunosuppression, Nrf2 inhibition
MeSH terms
Animals, Female, Humans, Melanoma, Mice, Inbred C57BL, Transcription, Genetic, Signal Transduction, Transcriptional Activation, Cell Line, Tumor, Mice, HEK293 Cells, B7-H1 Antigen

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Targeting the upstream transcriptional activator of PD-L1 as an alternative strategy in melanoma therapy. https://app.cochat.ai/papers/10.1038/s41388-018-0314-0
The paper
Zhu, B., Tang, L., Chen, S., Yin, C., Peng, S., Li, X., Liu, T., Liu, W., Han, C., Stawski, L., Xu, Z.-X., Zhou, G., Chen, X., Gao, X., Goding, C. R., Xu, N., Cui, R., & Cao, P. (2018). Targeting the upstream transcriptional activator of PD-L1 as an alternative strategy in melanoma therapy. Oncogene. https://doi.org/10.1038/s41388-018-0314-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.